Physiopathogenesis and Treatment of Liver Diseases France

Research

Date range: 1 September 2020 - 31 August 2021

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Physiopathogenesis and Treatment of Liver Diseases published between 1 September 2020 - 31 August 2021 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Physiopathogenesis and Treatment of Liver Diseases
Count Share
1 0.02

Outputs by subject (Share)

Outputs by subject
Subject Count Share
1 0.02

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
0.00 0.00 0.00 0.00 0.00

Compare Physiopathogenesis and Treatment of Liver Diseases with other institutions

Collaboration

Date range: 1 September 2020 - 31 August 2021

  • 59.29% Domestic
  • 40.71% International

Note: Hover over the graph to view the percentage of collaboration.

International vs. domestic collaboration by Share


Top 10 domestic collaborators with Physiopathogenesis and Treatment of Liver Diseases by Share (32 total)

  1. Physiopathogenesis and Treatment of Liver Diseases and Assistance Publique-Hôpitaux de Paris (AP-HP) (0.21)
    Physiopathogenesis and Treatment of Liver Diseases0.02
    0.19
  2. Physiopathogenesis and Treatment of Liver Diseases and University of Bordeaux (0.12)
    Physiopathogenesis and Treatment of Liver Diseases0.02
    0.10
  3. Physiopathogenesis and Treatment of Liver Diseases and National Infrastructure of Metabolomics and Fluxomics (MetaboHUB) (0.08)
    Physiopathogenesis and Treatment of Liver Diseases0.02
    0.06
  4. Physiopathogenesis and Treatment of Liver Diseases and National Institute for Health and Medical Research (INSERM) (0.05)
    Physiopathogenesis and Treatment of Liver Diseases0.02
    0.03
  5. Physiopathogenesis and Treatment of Liver Diseases and French National Centre for Scientific Research (CNRS) (0.03)
    Physiopathogenesis and Treatment of Liver Diseases0.02
    0.02
  6. Physiopathogenesis and Treatment of Liver Diseases and Imagine Institute (0.03)
    Physiopathogenesis and Treatment of Liver Diseases0.02
    0.02
  7. Physiopathogenesis and Treatment of Liver Diseases and Hémostase Inflammation Thrombose (HITh) (0.03)
    Physiopathogenesis and Treatment of Liver Diseases0.02
    0.02
  8. Physiopathogenesis and Treatment of Liver Diseases and Centre de Recherche sur l’Inflammation (CRI) (0.03)
    Physiopathogenesis and Treatment of Liver Diseases0.02
    0.02
  9. Physiopathogenesis and Treatment of Liver Diseases and University of Paris (0.02)
    Physiopathogenesis and Treatment of Liver Diseases0.02
    0.01
  10. Physiopathogenesis and Treatment of Liver Diseases and University of Paris-Sud (UPSud) (0.02)
    Physiopathogenesis and Treatment of Liver Diseases0.02
    0.01

Top 10 international collaborators with Physiopathogenesis and Treatment of Liver Diseases by Share (7 total)

  1. Physiopathogenesis and Treatment of Liver Diseases and The University of Georgia (UGA) (0.20)
    Physiopathogenesis and Treatment of Liver Diseases0.02
    0.19
  2. Physiopathogenesis and Treatment of Liver Diseases and Sanford Burnham Prebys Medical Discovery Institute (SBP) (0.14)
    Physiopathogenesis and Treatment of Liver Diseases0.02
    0.13
  3. Physiopathogenesis and Treatment of Liver Diseases and Imperial College London (ICL) (0.08)
    Physiopathogenesis and Treatment of Liver Diseases0.02
    0.06
  4. Physiopathogenesis and Treatment of Liver Diseases and Greenwood Genetic Center (GGC) (0.08)
    Physiopathogenesis and Treatment of Liver Diseases0.02
    0.06
  5. Physiopathogenesis and Treatment of Liver Diseases and Mayo Clinic (0.08)
    Physiopathogenesis and Treatment of Liver Diseases0.02
    0.06
  6. Physiopathogenesis and Treatment of Liver Diseases and University of Washington (UW) (0.08)
    Physiopathogenesis and Treatment of Liver Diseases0.02
    0.06
  7. Physiopathogenesis and Treatment of Liver Diseases and The Nemours Foundation (0.05)
    Physiopathogenesis and Treatment of Liver Diseases0.02
    0.03